🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
This is a prospective, open label, controlled, single center real-world obs...
Status
Recruiting
Location
National Clinical Research Center for Blood Diseases, Institute of Hematology & Blood Diseases Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College Hospital
Start Date
2025-05-19
Trial ID
NCT07135778
This is a single-center, single-arm, observational clinical study evaluatin...
Status
Recruiting
Location
Haikou Affiliated Hospital of Central South University Xiangya School of Medicine
Start Date
2025-08-01
Trial ID
NCT07763054
Treatments Being Tested
Background: Mucormycosis is a serious but rare fungal infection that requi...
Status
Active Not Recruiting
Location
Guangxi Medical University
Start Date
2025-05-15
Trial ID
NCT07191756
Treatments Being Tested
Background: \- Visceral leishmaniasis (VL) is an infection caused by paras...
Status
Withdrawn
Location
Kala-Azar Medical Research Center (KAMRC), Rambag Road
Start Date
TBD
Trial ID
NCT01437020
Treatments Being Tested
The purpose of this study is to determine if EL219 is safe and effective co...
Status
Recruiting
Location
U. of Alabama at Birmingham
Start Date
2026-02-13
Trial ID
NCT07215273
Treatments Being Tested
This protocol will evaluate the efficacy and safety of various combinations...
Status
Completed
Location
Bhaluka UZHC
Start Date
2010-05
Trial ID
NCT01122771
The overall objective of this trial is to identify a safe and effective com...
Status
Completed
Location
Kala-azar medical centre
Start Date
2008-06
Trial ID
NCT00696969
This is a phase II, multicentre, randomized, two-arm blinded study with an ...
Status
Completed
Location
DrugsNeglectedD Investigational Site
Start Date
2022-12-27
Trial ID
NCT05593666
The study aims to investigate whether prophylaxis with liposomal amphoteric...
Status
Completed
Location
Gilead Sciences
Start Date
2011-04
Trial ID
NCT01259713
Treatments Being Tested
The safety and effectiveness of AmBisome 15 mg/kg, given over 15 days in 5 ...
Status
Completed
Location
Multiple Locations
Start Date
2014-04-08
Trial ID
NCT03311607
Treatments Being Tested